Detalhe da pesquisa
1.
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy.
Mod Pathol
; 33(9): 1832-1843, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32376853
2.
Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
Histopathology
; 77(6): 890-899, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32639612